Abstract
Background There is a notion that tobacco smoking would have weight control effect based on the appetite suppressive effect of nicotine. However, a causal effect from being an ever smoker on obesity-related traits in the general population has yet been determined.
Methods This Mendelian randomization (MR) analysis instrumented 378 genetic variants associated with being an ever smoker which mostly initiated in adolescents or young adulthood, identified from a genome-wide association study (GWAS) meta-analysis of 1.2 million individuals. The outcome data for body mass index, waist circumference, hip circumference, and waist-to-hip ratio was collected in 337,318 white British ancestry UK Biobank participants with 40-69 ages. Replication analysis was performed for GWAS meta-analysis for body mass index including the GERA/GIANT data including 364,487 mostly European samples. Summary-level MR by inverse variance weighted method and pleiotropy-robust MR methods, including median-based and MR–Egger regression, was performed.
Results Summary-level MR analysis indicated that genetically predicted being an ever smoker is causally linked to higher body mass index [+0.28 (0.18, 0.38) kg/m2], waist circumference [+0.88 (0.66, 1.10) cm], hip circumference [+0.40 (0.23, 0.57) cm], and waist-to-hip ratio [+0.006 (0.005, 0.007)]. The results were consistently supported by pleiotropy-robust MR analysis. In the replication analysis, genetically predicted being an ever smoker was again significantly associated with higher body mass index [+0.03 (0.01, 0.05) kg/m2].
Conclusion Initiation of tobacco use may consequently lead to worse obesity-related traits of the general population in middle-to-old ages.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was supported by a grant of the MD-Phd/Medical Scientist Training Program through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea. This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT, Ministry of Science and ICT) (No. 2021R1A2C2094586). The study was performed independently by the authors.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the institutional review boards of Seoul National University Hospital (No. E-2203-053-1303) and the UK Biobank consortium (application No. 53799).9,10 The study was performed in accordance with the Declaration of Helsinki. The requirement for informed consent was waived by the attending institutional review boards because public anonymous database collected for research purpose was used for this study.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The data used for this study is available in the public database. The CKDGen data is openly available in the consortium website (URL: https://ckdgen.imbi.uni-freiburg.de/) and the UK Biobank data is accessible after acquiring approval from the organization (application No. 53799).
